文献速递乳腺MR

乳腺MR成像用于评估乳腺癌初次手术后切缘阳性患者的残留病变

Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins.
PubMed 文献 · Eur Radiol · 2017-05-31

本研究为回顾性研究,纳入175例乳腺癌初次手术后切缘阳性并接受术后MR检查的患者,由两名专家独立评估手术腔残留病变及多灶/多中心病变,并与最终手术病理对照。结果显示,术后乳腺MR能准确显示手术腔≥5 mm的残留病变及未知的多灶/多中心病变,可能有助于更恰当地选择二次手术方式。

要点

  • 术后乳腺MR可准确显示手术腔≥5 mm的残留病变。
  • 手术腔残留病变的敏感度在浸润性癌和导管原位癌中均较高。
  • 术后改变与非常小的残留病变(<5 mm)可能存在重叠。

核心结论

  • 术后乳腺MR能准确显示手术腔≥5 mm的残留病变及未知的多灶/多中心病变,这些发现可能有助于更恰当地选择切缘阳性女性的二次手术方式。

研究设计与样本

  • 经IRB批准、符合HIPAA的回顾性研究,纳入175例乳腺癌初次手术后切缘阳性并接受MR检查的患者,两名专家独立重新评估MR图像,所有患者均接受确定性手术并将MR表现与组织病理学对照。

关键影像表现/征象

  • 手术腔残留病变的总体平均敏感度、特异度、PPV和NPV分别为73%、72%、91%和45%。
  • 读者1识别出42/45(93%)手术腔残留浸润性病变≥5 mm的患者,读者2识别出43/45(95%)。
  • 两名读者均识别出22/22(100%)病变≥10 mm的患者。
  • 未知多灶/多中心病变的平均敏感度、特异度、PPV和NPV分别为90%、96%、93%和86%。

诊断标准与关键数值

  • 手术腔残留病变≥5 mm:读者1敏感度93%(42/45),读者2敏感度95%(43/45)。
  • 手术腔残留病变≥10 mm:两名读者敏感度均为100%(22/22)。
  • 手术腔残留病变总体平均敏感度73%、特异度72%、PPV 91%、NPV 45%。
  • 未知多灶/多中心病变平均敏感度90%、特异度96%、PPV 93%、NPV 86%。

临床应用与阅片要点

  • 术后乳腺MR可准确显示手术腔≥5 mm的残留病变,阅片时应关注手术腔≥5 mm的残留病变。
  • 术后改变与非常小的残留病变(<5 mm)可能存在重叠,阅片时需注意鉴别。
  • 术后乳腺MR可能有助于规划准确的再切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the accuracy of post-operative MR in predicting residual disease in women with positive margins, emphasizing the size thresholds at which residual disease can be confidently identified.

METHODS: This IRB-approved HIPAA-compliant retrospective study included 175 patients with MR after positive margins following initial surgery for breast cancer. Two expert readers independently re-evaluated MR images for evidence of residual disease at the surgical cavity and multifocal/multicentric disease. All patients underwent definitive surgery and MR findings were correlated to histopathology.

RESULTS: 139/175 (79.4%) patients had residual disease at surgery. Average overall sensitivity, specificity, PPV and NPV for residual disease at the surgical cavity were 73%, 72%, 91% and 45%, respectively. The readers identified 42/45 (93%, reader 1) and 43/45 (95%, reader 2) patients with residual invasive disease at the cavity of ≥5 mm and 22/22 (100%, both readers) patients with disease ≥10 mm. Average sensitivity, specificity, PPV and NPV for unknown multifocal/multicentric disease were 90%, 96%, 93% and 86%, respectively.

CONCLUSIONS: Post-operative breast MR can accurately depict ≥5-mm residual disease at the surgical cavity and unsuspected multifocal/multicentric disease. These findings have the potential to lead to more appropriate selection of second surgical procedures in women with positive margins.

KEY POINTS: • Post-operative breast MRI accurately defines residual disease of ≥5 mm. • Surgical cavity sensitivities were high for both invasive carcinoma and DCIS. • Post-surgical changes and very small residual disease (<5 mm) may overlap. • Post-operative breast MRI may help planning an accurate re-resection.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Krammer J, Price ER, Jochelson MS, et al. Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins. Eur Radiol. 2017. PMID: 28567547. doi:10.1007/s00330-017-4823-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。